Nisa Investment Advisors, LLC Vaxart, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.41 $79 - $187	133 New	133 $0
Q2 2022 Aug 03, 2022	SELL	$2.7 - $5.28 $11,232 - $21,964	-4,160 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$4.29 - $6.64 $17,846 - $27,622	4,160 New	4,160 $21,000
Q4 2021 Feb 03, 2022	SELL	$5.77 - $7.96 $85,973 - $118,604	-14,900 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$3.5 - $7.98 $41,692 - $95,057	11,912 Added 398.66%	14,900 $85,000
Q3 2020 Oct 20, 2020	BUY	$4.78 - $16.97 $14,282 - $50,706	2,988 New	2,988 $20,000

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.